Sort   by:  
 Page size 
UnknownCetuximab activity in dysplastic lesions of the upper aerodigestive tract.
Not available
S-EPMC7751887 | biostudies-literature
UnknownKinin b2 receptor mediates induction of cyclooxygenase-2 and is overexpressed in head and neck squamous cell carcinomas.
Not available
S-EPMC3575100 | biostudies-literature
UnknownTargeting GPCR-mediated p70S6K activity may improve head and neck cancer response to cetuximab.
Not available
S-EPMC3149755 | biostudies-literature
UnknownMolecular and Clinical Activity of CDX-3379, an Anti-ErbB3 Monoclonal Antibody, in Head and Neck Squamous Cell Carcinoma Patients.
Not available
S-EPMC6820348 | biostudies-literature
UnknownEpidemiology of head and neck squamous cell cancer among HIV-infected patients.
Not available
S-EPMC3999230 | biostudies-literature
UnknownAntitumor effects of EGFR antisense guanidine-based peptide nucleic acids in cancer models.
Not available
S-EPMC3684443 | biostudies-literature
UnknownThe degree of intratumor mutational heterogeneity varies by primary tumor sub-site.
Not available
S-EPMC5053641 | biostudies-literature
UnknownTherapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma.
Not available
S-EPMC8592538 | biostudies-literature
UnknownCaveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer.
Not available
S-EPMC8564908 | biostudies-literature
UnknownA protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity.
Not available
S-EPMC9005332 | biostudies-literature
Sort   by:  
 Page size